This study of a previously undescribed association between positive infectious mononucleosis (IM) serology and anticonvulsant therapy was prompted by a chance observation in a 31-year-old housewife receiving long-term primidone for idiopathic epilepsy. In April 1972, she was suspected of having IM when she presented to her general practitioner with sore throat and cervical lymphadenopathy. Laboratory investigation revealed a normal blood picture, a positive IM slide test but a negative differential absorption sheep cell test. When identical results were obtained three weeks later it was concluded that the positive IM slide reaction was likely to be of a false positive nature, particularly as the patient was now symptom free. This anomaly led us to examine the sera of a group of randomly selected epileptic outpatients, and similar results were obtained. This report aims to substantiate these preliminary observations and describes exploratory investigations into their possible significance.
Patients studied
One hundred and seventy-seven mentally subnormal patients from the long-stay Ladysbridge Hospital, Banffshire were studied: 115 (63 males, 52 females) ' Present address: Haematology Unit, University of Aberdeen Received for publication 28 May 1975. were epileptics receiving anticonvulsant drugs and 62 (35 males, 27 females) were non-epileptic control patients. The age distribution of the two groups is depicted in the figure. No patient with chromosomal or known immunological abnormality was included. All were in their usual health and in particular none had suffered from sore throat or a glandular fever like illness in the previous six months.
Laboratory Investigations
Haematological examination comprised Coulter 'S' profile (Coulter Electronics Inc., Harpenden, Herts, UK), microscopy of a stained blood film, derivation of a differential white cell count, and a direct antiglobulin test in all subjects.
Serological investigations included initial screening of the sera of all patients with three commercial IM slide kits-Monospot (Ortho Diagnostics Ltd, Raritan, New Jersey, USA); Monosticon (NV Organon, Oss, Holland) and Oxoid (Oxoid Ltd, London, UK). Any serum giving a positive reaction with one or more of these tests was then subjected to a conventional differential absorption test (Davidson, 1967 Armitage, 1971) .
These findings confirm our initial observations and suggest a possible link between the occurrence and persistence of IM slide positivity and anticonvulsant therapy.
COMPARISON OF THE DIFFERENT SLIDE TEST SENSITIVITIES
Of considerable interest and practical importance is the difference in the number of positive reactions givein by the three different slide tests used to detect IM heterophile antibody. Monospot was the most sensitive reagent, identifying 27/35 (70 %) sera initially positive and 25/27 (89%) positive on reexamination six months later. The Oxoid reagent detected 19/29 (49%) and 13/27 (49%o) while Monosticon detected 18/39 (46%) and 11/27 (41 %).
The higher rates of detection of Monospot over the other two reagents were highly significant (X2 = 11-8 and 15-5; p < 0-001). The concurrence of the results, measured by correlation coefficient analysis, comparing Monospot with Oxoid and Monospot with Monosticon was high (r = 0-77; r = 0 74), but the correlation between the two weaker detectors was relatively low (r = 0 33). Such discrepant findings emphasize the need for further study and evaluation of factors influencing the sensitivity and specificity of these reagents in diagnostic serology.
HAEMATOLOGICAL EXAMINATION AND SLIDE TEST POSITIVITY
Only two abnormal white cell patterns emerged, a mild neutropenia in those receiving anticonvulsant drugs (X2 = 4-20, p < 0 05) and a high incidence of eosinophilia (> 440 eosinophils x 109/l) in both control (13 %) and epileptic (14 %) patients. Atypical mononuclear cells were not detected in significant numbers in the peripheral blood of any patient and we were unable to confirm the previously reported association of phenytoin hypersensitivity and the (Wood and Frenkel, 1967 Multiple drug regimens were commonly used in the treatment of these epileptic patients and hence the role and contribution of any one anticonvulsant was difficult to assess. Only 5/32 positive epileptic slide reactors were not receiving phenobarbitone or primidone, the therapeutic effect of which depends upon its metabolic degradation to phenobarbitone (Bogan and Smith, 1968) (Sorrell et al, 1971; Grob and Herold, 1972) with the consequent defective immunosurveillance leading in rare instances to malignant transformation within the reticuloendothelial system (Editorial, 1971) . In the epileptic patients we have studied, anticonvulsant therapy may thus be altering immunoregulatory mechanisms, thereby favouring atypical or even inappropriate humoral responses which included the development and persistence of an IM slide detectable heterophile antibody. Although the nature of the underlying immunogenic stimulus has not been identified, our findings indicate that it is not the potentially oncogenic EB virus (Epstein and Achong, 1973) .
The high incidence (11 %) of slide positivity in controls was unexpected and remains unexplained.
Such an incidence is much higher than that (1 to 2 %) usually associated with this diagnostic technique (Glade, 1972) . The specificity of slide testing, however, has generally been assessed by comparing the results in known cases of IM with those in randomly selected controls. False positive tests have been reported in patients with viral infections including infectious hepatitis, cytomegalovirus, adenovirus, and rubella (Seitanidis, 1969; Wahren, 1969; Phillips, 1972) 
